在阻塞性睡眠呼吸暂停中,持续正气道压力与夜间氧气相比:一种倾向性得分匹配研究
Carlos Granados-Burgos1, Eduardo Tuta-Quintero2, Paula Romero2
1School of Medicine, Universidad de La Sabana, Chía 250001, Colombia.
Advances in respiratory medicine
|February 20, 2026
概括
与夜间氧气治疗 (NOT) 相比,持续的正气压 (CPAP) 治疗与阻塞性睡眠呼吸暂停 (OSA) 患者的五年生存率更好相关. CPAP表现出优异的结果,支持其作为OSA的主要治疗方法的使用.
科学领域:
- 肺部病理学 肺部病理学
- 睡眠医学 睡眠医学
- 心血管风险管理心血管风险管理
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 显著影响生活质量,并增加心血管风险.
- 夜间氧气疗法 (NOT) 为无法忍受持续正气道压力 (CPAP) 治疗的患者提供了替代方案.
研究的目的:
- 用NOT治疗的阻塞性睡眠呼吸暂停 (OSA) 患者和持续正气道压力 (CPAP) 患者之间的五年生存率进行比较.
- 评估CPAP与NOT在治疗OSA中的长期疗效.
主要方法:
- 使用倾向得分匹配 (PSM) 进行回顾性队列研究,以最大限度地减少选择偏差.
- 分析包括497名被诊断患有OSA的患者,分为两组:CPAP治疗 (303名患者) 和NOT (194名患者).
- 使用PSM建立了370名患者 (185人/组) 的匹配队列,通过标准化平均差异评估平衡.
主要成果:
- 接受CPAP治疗的组表现出明显较低的残留呼吸暂停-呼吸暂停指数 (3.9对15; p < 0.001),表明更好的生理控制.
- 与NOT相比,CPAP治疗与死亡风险大幅降低有关 (加权后勤回归OR = 0.11;p = 0.004).
- 倾向性得分匹配进一步证实了CPAP的益处,显示死亡风险显著降低 (ATT = -0.12; p = 0.030).
结论:
- 与接受补充氧气治疗的患者相比,用CPAP治疗的OSA患者的五年生存率较高.
- 这些发现支持CPAP作为阻塞性睡眠呼吸暂停的首选一线治疗方法,因为它与长期结果的良好关联.
- CPAP疗法为患有OSA的人提供了更好的生理控制和更好的生存益处.
相关概念视频
Sleep Apnea
618
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
618
Mechanical Ventilation III: Noninvasive Ventilation
639
Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
Noninvasive Positive-Pressure Ventilation...
639
Hyperpnea and Hyperventilation
3.1K
Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...
3.1K
Chronic Obstructive Pulmonary Disease
2.7K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.7K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.2K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.2K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
652
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
652


